Karuna Therapeutics, Inc.
NASDAQ:KRTX
329.83 (USD) • At close March 15, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 185.823 | 248.329 | 206.953 | 53.048 | 208.929 | 85.526 | 1.942 |
| Short Term Investments
| 1,076.99 | 875.715 | 287.038 | 269.282 | 180.468 | 4.983 | 0 |
| Cash and Short Term Investments
| 1,262.813 | 1,124.044 | 493.991 | 322.33 | 389.397 | 90.509 | 1.942 |
| Net Receivables
| 4.9 | 0.057 | 1.75 | 0 | 0 | 0 | 0 |
| Inventory
| 32.831 | 28.325 | 20.885 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 14.769 | 2.343 | 0.708 | 1.088 | 0.485 | 0.023 | 0.008 |
| Total Current Assets
| 1,315.313 | 1,154.769 | 517.334 | 344.599 | 392.706 | 92.218 | 2.117 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 20.514 | 7.875 | 9.545 | 2.869 | 0.195 | 0.138 | 0.012 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | -1.464 | -1.922 | -0.812 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.261 | 0.261 | 0.157 | 0.123 | 0 | 0 |
| Tax Assets
| 0 | 1.203 | 1.661 | 0.655 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.382 | 0.69 | 0.792 | 0.157 | 0 | 0.123 | 0 |
| Total Non-Current Assets
| 20.896 | 8.565 | 10.337 | 3.026 | 0.318 | 0.261 | 0.012 |
| Total Assets
| 1,336.209 | 1,163.334 | 527.671 | 347.625 | 393.024 | 92.479 | 2.129 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 6.783 | 2.379 | 1.939 | 0.865 | 0.547 | 0.269 | 0.798 |
| Short Term Debt
| 2.843 | 2.282 | 2.175 | 0.844 | 0.058 | 0 | 7.674 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 41.609 | 0 | 0 | 0 | 0 | 0 | 0.433 |
| Other Current Liabilities
| 16.894 | 29.285 | 16.099 | 5.144 | 2.353 | 0.538 | 2.606 |
| Total Current Liabilities
| 68.129 | 33.946 | 20.213 | 6.853 | 2.958 | 0.807 | 11.511 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 13.845 | 3.046 | 5.328 | 1.841 | 0.15 | 0.102 | 3.985 |
| Deferred Revenue Non-Current
| 0 | -1.203 | -1.661 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 1.203 | 1.661 | 0.655 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0.104 | 0.104 | -0.655 | 0 | 0 | 0.001 |
| Total Non-Current Liabilities
| 13.845 | 3.15 | 5.432 | 1.841 | 0.15 | 0.102 | 3.986 |
| Total Liabilities
| 81.974 | 37.096 | 25.645 | 8.694 | 3.108 | 0.909 | 15.497 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 393.024 | 0 | 0 |
| Common Stock
| 0.004 | 0.003 | 0.003 | 0.003 | 0.003 | 0.001 | 0 |
| Retained Earnings
| -997.887 | -564.207 | -287.871 | -144.066 | -75.512 | -32.102 | -14.043 |
| Accumulated Other Comprehensive Income/Loss
| 0.211 | -3.29 | -0.497 | 0.039 | 0.005 | -0.007 | -0.001 |
| Other Total Stockholders Equity
| 2,251.907 | 1,693.732 | 790.391 | 482.955 | 72.396 | 123.678 | 0.676 |
| Total Shareholders Equity
| 1,254.235 | 1,126.238 | 502.026 | 338.931 | 389.916 | 91.57 | -13.368 |
| Total Equity
| 1,254.235 | 1,126.238 | 502.026 | 338.931 | 389.916 | 91.57 | 0 |
| Total Liabilities & Shareholders Equity
| 1,336.209 | 1,163.334 | 527.671 | 347.625 | 393.024 | 92.479 | 2.129 |